These compounds may interact with:
Activated CDC42 kinase 1
Potentially involved in: carcinoma; cancer; liver neoplasms; precancerous conditions; atypical teratoid / rhabdoid tumor; medulloblastoma, large-cell; oligodendroglioma; osteosarcoma; posterior fossa group b ependymoma; sonic hedgehog group medulloblastoma; philadelphia chromosome positive chronic myelocytic leukemia; philadelphia chromosome-positive acute lymphoblastic leukemia; blastic phase chronic myeloid leukemia; chronic phase chronic myeloid leukemia; chronic myelocytic leukemia accelerated phase
Disease data sourced from Pharos.